Evidence map›Paper›PMID 40747493›Full record

ArticleFrontiers in cardiovascular medicine2025

Severe attenuation of circadian clock output in the heart following sustained augmentation of cardiomyocyte protein O-GlcNAcylation.

Gobinath Shanmugam, Samuel F Chang, Helen E Collins, Chae-Myeong Ha, Mariame S Kane, Luke Potter, Lily Xie, Luyun Zou, Jianhua Zhang, John C Chatham and 2 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gobinath ShanmugamDivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Samuel F ChangDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Helen E CollinsDivision of Environmental Medicine, Department of Medicine, Center for Cardiometabolic Science, University of Louisville, Louisville, KY, United States.
Chae-Myeong HaDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Mariame S KaneDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Luke PotterDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Lily XieDivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Luyun ZouDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Jianhua ZhangDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
John C ChathamDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Adam R WendeDivision of Molecular Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Martin E YoungDivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008361 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YACOUBIAN, TALENE ALENE · 1992 to 2024
$16.8M
Nox4 and Epigenetics in chronically enhanced cardiac protein O-GlcNAcylationF30HL172687 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Samuel Formosa Chang · 2024 to 2026
$130k
NHLBI NIH HHS F30 HL172687NIGMS NIH HHS T32 GM008361
6 · The paper itself

Abstract

Background: Changes in circadian-related behaviors (e.g., the timing of food intake, sleep cycles) and the environment (e.g., light-dark cycles) increase the risk of numerous cardiometabolic diseases, including diabetes mellitus and cardiac disease. Recent studies indicate a close interrelationship between circadian clocks and the posttranslational modification, protein O-GlcNAcylation. The current study was designed to investigate whether a modest elevation of protein O-GlcNAcylation in the adult mouse heart, similar to levels observed during pathologic states, influenced circadian governance of the heart. Methods and results: Cardiomyocyte-specific expression of a dominant negative O-GlcNAcase (dnOGAh) for a 2-week period resulted in an approximate 1.5-fold increase in cardiac protein O-GlcNAcylation, impacting 70% of core circadian clock components in the heart at the mRNA level. Further interrogation of cardiac mRNA species in dnOGAh hearts at candidate (RT-PCR) and unbiased (RNAseq) levels revealed a 95% loss of circadian governance of the cardiac transcriptome. This was despite persistent/augmented 24 h oscillations of the core circadian clock proteins BMAL1, REVERB Conclusions: Sustained protein O-GlcNAcylation in the heart causes loss of circadian governance, likely downstream of the core circadian clock mechanism. Moreover, interstitial fibrosis appears to be a universal adverse outcome following impaired circadian governance.

Indexed as

chronobiologyfibrosisgene expressionglycobiologypost-translational modification

Identifiers

PMID40747493
PMCPMC12310464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.